Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

Background: In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates. Objective of study: To observe the clinical eff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seyed MohammadReza Hashemian, Navid Shafigh, Golnaz Afzal, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Majid Malekmohammad, Seyed Mehdi Mortazavi, Batoul Khoundabi, Davood Mansouri, Afshin Moniri, Abbas Hajifathali, Elham Roshandel, Esmaeil Mortaz, Ian M Adcock
Formato: article
Lenguaje:EN
Publicado: Elsevier España 2021
Materias:
ARDS
Critically ill COVID-19
Blood purification
Plasmapheresis
Cytokine storm
Diseases of the respiratory system
RC705-779
Acceso en línea:https://doaj.org/article/251c71fa0b174c62b8732e1118d1ffd1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/251c71fa0b174c62b8732e1118d1ffd1

Ejemplares similares